Position in NVO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$44,823
-$6,774 QoQ
Shares Held
935
-33.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,127
of 1,348 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Frazier Financial Advisors, LLC holds $5,122,500 across 11 Drug Manufacturers - General names. NVO ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
16,576 | $4,171,184 | |
| 2 | JNJ |
Johnson & Johnson
|
1,921 | $487,876 | |
| 3 | LLY |
ELI LILLY & Co
|
147 | $176,316 | |
| 4 | PFE |
Pfizer Inc
|
2,529 | $60,898 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
883 | $50,878 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
935 | $44,823 | |
| 7 | AMGN |
Amgen Inc
|
122 | $44,178 | |
| 8 | NVS |
Novartis AG
|
200 | $31,344 |
All Filings in NVO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,823 | 935 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $51,597 | 1,404 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $227,840 | 4,478 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $162,474 | 2,928 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $188,286 | 2,728 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $163,670 | 2,357 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $195,007 | 2,267 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $282,195 | 2,370 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $264,925 | 1,856 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $223,159 | 1,738 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $157,554 | 1,523 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||